Saturday, December 22, 2012 1:29:34 AM
All of them have control arms using carboplatin + paclitaxel, same as in the Bavi first-line trial.
I have highlighted in blue the maximums for each column. The Avastin trial still holds the record for largest
percentage increase in MOS (19.4%). If the Bavi first-line trial comes in with a control arm MOS of 13 months
and a treatment arm MOS of 17 months it would be an increase of 31%, still very good in comparison.
Recent CDMO News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
